Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medtronic revenue decreased from $30.6 billion in 2019 to $28.9 billion in 2020, a (5.4%) decrease.
Annual Revenue ($)
Medtronic revenue was $28.91 b in FY, 2020 which is a (5.4%) year over year decrease from the previous period.
Quarterly Revenue ($)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Medtronic revenue breakdown by business segment: 8.2% from Diabetes Group, 28.9% from Minimally Invasive Therapies Group, 36.2% from Cardiac and Vascular Group and 26.7% from Restorative Therapies Group
Medtronic revenue breakdown by geographic segment: 51.6% from United States, 32.1% from Non-U.S. Developed Markets and 16.3% from Emerging Markets
| FY, 2020 | FY, 2019 | FY, 2018 | |
|---|---|---|---|
| Minimally Invasive Therapies Group | $8.35 b | $8.48 b | $8.72 b |
| Cardiac and Vascular Group | $10.47 b | $11.51 b | $11.35 b |
| Restorative Therapies Group | $7.73 b | $8.18 b | $7.74 b |
| Diabetes Group | $2.37 b | $2.39 b | $2.14 b |
| FY, 2020 | FY, 2019 | FY, 2018 | |
|---|---|---|---|
| United States | $14.92 b | $16.19 b | $15.88 b |
| Ireland | $91 m | $85 m | |
| Rest of World | $14.27 b | $13.99 b | |
| Non-U.S. Developed Markets | $9.29 b | ||
| Emerging Markets | $4.71 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.